Presentations & Webcasts

Corporate Presentation

August 6, 2026

Half Year Results 2026

April 23, 2026

Full Year Results 2025

December 4, 2025

Q3 Results 2025

December 4, 2025
Presentation Q3 Results 2025

September 4, 2025
Presentation Half Year Results 2025

June 17, 2025
Presentation Q1 Results 2025

April 29, 2025
Presentation Full Year Results 2024

February 18, 2025
Presentation Virtual R&D Update with KOL Speakers

December 10, 2024
Presentation Third Quarter Results 2024

September 30, 2024
Virtual Kidney Disease KOL event

September 12, 2024
Presentation January – June 2024

July 18, 2024
Presentation R&D Update call

May 23, 2024
Presentation First Quarter Results 2024

April 24, 2024
Presentation Full Year Results 2023

December 06, 2023
Presentation Third Quarter Results 2023

November 14, 2023
Jefferies London Healthcare Conference 2023
Link to webcast

October 17, 2023
Featured presentations and a moderated panel discussion on the design and rationale of the VIVIAD Phase 2b study of varoglutamstat in Alzheimer’s disease followed by Q&A
Virtual R&D Event with Key Opinion Leaders

October 11, 2023
Jefferies Inaugural Biotech CNS/Neuro Summit 2023
Link to webcast

September 07, 2023
Presentation January – June 2023

March 16, 2023
Barclays 2023 Global Healthcare Conference
Link to webcast

April 19, 2023
Presentation Results 2022

November 22, 2022
Presentation Q3 2022

September 30, 2022
Presentation January – June 2022

April 15 2021
Addressing the Alzheimer´s Disease Puzzle in the Clinic: An Expert Overview, A virtual R&D Day with Professor Philip Scheltens, Professor Howard Feldman and Dr. Frank Weber
Link to virtual R&D Day

April 28, 2022
Presentation Results 2021

September 21, 2021
Presentation Results January – June 2021